Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001493152-26-024426
Filing Date
2026-05-19
Accepted
2026-05-19 16:30:58
Documents
69
Period of Report
2026-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q form10-q.htm   iXBRL 10-Q 1640216
2 EX-10.2 ex10-2.htm EX-10.2 20734
3 EX-31.1 ex31-1.htm EX-31.1 12169
4 EX-31.2 ex31-2.htm EX-31.2 12094
5 EX-32.1 ex32-1.htm EX-32.1 7888
6 EX-32.2 ex32-2.htm EX-32.2 8156
7 GRAPHIC form10-q_001.jpg GRAPHIC 4645
8 GRAPHIC form10-q_002.jpg GRAPHIC 18598
9 GRAPHIC form10-q_003.jpg GRAPHIC 8323
10 GRAPHIC form10-q_004.jpg GRAPHIC 8950
11 GRAPHIC form10-q_005.jpg GRAPHIC 13482
  Complete submission text file 0001493152-26-024426.txt   9163696

Data Files

Seq Description Document Type Size
12 XBRL SCHEMA FILE mgrx-20260331.xsd EX-101.SCH 65134
13 XBRL CALCULATION FILE mgrx-20260331_cal.xml EX-101.CAL 54444
14 XBRL DEFINITION FILE mgrx-20260331_def.xml EX-101.DEF 356661
15 XBRL LABEL FILE mgrx-20260331_lab.xml EX-101.LAB 551035
16 XBRL PRESENTATION FILE mgrx-20260331_pre.xml EX-101.PRE 448119
72 EXTRACTED XBRL INSTANCE DOCUMENT form10-q_htm.xml XML 1238395
Mailing Address 15110 DALLAS PKWY, SUITE 600 DALLAS TX 75248
Business Address 15110 DALLAS PKWY, SUITE 600 DALLAS TX 75248 (833) 626-4679
MANGOCEUTICALS, INC. (Filer) CIK: 0001938046 (see all company filings)

EIN.: 873841292 | State of Incorp.: TX | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-41615 | Film No.: 26999361
SIC: 8090 Services-Misc Health & Allied Services, NEC
(CF Office: 08 Industrial Applications and Services)